Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir
Clinical trial NCT05423834 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05423834
- Sponsor
- Chinese University of Hong Kong
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-01
- Primary completion
- 2025-12-21
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.